118th Congress · HOUSE BILLBILL

H.R. 1526 — Reducing Hereditary Cancer Act

“To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.”

Health

Introduced Mar 9, 2023

Last action Dec 17, 2024

Pipeline · Bill → Law

Step 1

Introduced

Mar 9, 2023

Step 2

Referred

Dec 17, 2024

E&C · Ways & Means

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Provisions · 4 sectionsIntroduced in House

Timeline · 5 actions

Dec 17, 2024

Referred to the Subcommittee on Health.

Mar 17, 2023

Referred to the Subcommittee on Health.

Mar 9, 2023

Introduced in House

Mar 9, 2023

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Mar 9, 2023